Rebecca Weil
Corporate Officer/Principal bij OCULIS HOLDING AG
Actieve functies van Rebecca Weil
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OCULIS HOLDING AG | Corporate Officer/Principal | 11-09-2023 | - |
Loopbaan van Rebecca Weil
Eerdere bekende functies van Rebecca Weil
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IDORSIA LTD | Verkoop & Marketing | 01-07-2019 | 01-08-2023 |
SHIRE | Corporate Officer/Principal | 01-08-2016 | 01-03-2019 |
Juvenile Diabetes Research Foundation (New York) | Directeur/Bestuurslid | - | - |
BAUSCH + LOMB CORPORATION | Verkoop & Marketing | - | - |
NOVARTIS AG | Corporate Officer/Principal | - | - |
ALCON INC. | Corporate Officer/Principal | - | - |
Opleiding van Rebecca Weil
Massachusetts Institute of Technology | Doctorate Degree |
Princeton University | Undergraduate Degree |
Statistieken
Internationaal
Zwitserland | 5 |
Verenigde Staten | 4 |
Ierland | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Sales & Marketing | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 7 |
Finance | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
OCULIS HOLDING AG | Health Technology |
IDORSIA LTD | Health Technology |
ALCON INC. | Health Technology |
NOVARTIS AG | Health Technology |
BAUSCH + LOMB CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Juvenile Diabetes Research Foundation (New York) |
- Beurs
- Insiders
- Rebecca Weil
- Ervaring